VRTX Operating Cash Flow (Statement)

Vertex Pharmaceuticals · Operating Cash Flow (Statement)

VRTX logo

VRTX Operating Cash Flow (Statement)

Latest reported$4.29B
VRTX TTM Cash from Operations (-$5.30M → $4.29B)
High-resolution chart · PNG

VRTX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
4,292,900,000
4,240,600,000
3,631,400,000
3,718,000,000
3,846,400,000
-980,300,000
-492,600,000
-842,600,000
-944,000,000
3,944,000,000
3,537,300,000
4,381,100,000
4,068,200,000
4,073,600,000
4,129,900,000
4,046,493,000
4,018,212,000
2,678,645,000
2,643,500,000
2,140,039,000
2,120,568,000
3,358,862,000
3,253,505,000
3,207,981,000
2,635,022,000
2,060,244,000
1,569,330,000
1,437,900,000
1,484,459,000
1,342,413,000
1,270,286,000
1,183,219,000
971,957,000
831,907,000
844,942,000
762,155,000
657,725,000
516,932,000
236,103,000
75,365,000
-37,315,000
-173,388,000
-365,432,000
-471,288,000
-511,911,000
-544,618,000
-513,199,000
-362,474,000
-288,547,000
-161,554,000
-51,570,000
-39,866,000
79,815,000
199,147,000
267,841,000
730,945,000
667,879,000
333,279,000
143,735,000
-526,031,000
-732,916,000
-625,608,000
-635,442,000
-571,666,000
-429,311,000
-438,489,000
-427,586,000
-422,484,000
-528,329,000
-306,506,000
-226,482,000
-181,949,000
-118,110,000
-290,203,000
-252,476,000
-204,071,000
-38,928,000
-29,575,000
-22,475,000
-25,191,000
-183,004,000
-177,932,000
-172,054,000
-188,693,000
-176,057,000
-145,118,000
-142,160,000
-147,219,000
-152,076,000
-169,423,000
-167,623,000
-152,398,000
-122,152,000
-99,330,000
-79,539,000
-23,806,000
-44,580,000
-29,831,000
-8,074,000
-64,154,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.